Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. [electronic resource]
Producer: 20060106Description: 1553-62 p. digitalISSN:- 1526-632X
- Aged
- Aged, 80 and over
- Alzheimer Disease -- drug therapy
- Amyloid beta-Peptides -- antagonists & inhibitors
- Antibodies -- blood
- Brain -- drug effects
- Cognition Disorders -- drug therapy
- Double-Blind Method
- Drug Administration Schedule
- Female
- Humans
- Immunotherapy, Active -- adverse effects
- Injections, Intramuscular
- Magnetic Resonance Imaging
- Male
- Meningoencephalitis -- chemically induced
- Middle Aged
- Neuropsychological Tests
- Peptide Fragments -- antagonists & inhibitors
- Placebos
- Treatment Outcome
- Vaccines -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.